The genetic key to a rare disease and its impact on orthopedics

Orthopedics

Volumn 29, Issue 8, 2006, Pages 672-

  Wolf, Jennifer M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN 4; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1;

BASE PAIRING; CLINICAL TRIAL; EDITORIAL; GENETIC SUSCEPTIBILITY; HALLUX VALGUS; HETEROTOPIC OSSIFICATION; HUMAN; ILIAC CREST; LINKAGE ANALYSIS; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; ORTHOPEDICS; OSSIFICATION; OSSIFYING MYOSITIS; SPINE FUSION; SPINE SURGERY; SURGICAL SPONGE; TOE MALFORMATION;

EID: 33747806977     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20060801-16     Document Type: Editorial

References (3)

1. Shore EM, Xu M, Feldman GJ, Fenstermacher DA; FOP International Research Consortium; Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38:525-527.
2. Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine. 2005; 3:436-443.
3. Vaccaro AR, Anderson DG, Patel T, et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine. 2005; 30:2709-2716.